0001127602-14-016878.txt : 20140508
0001127602-14-016878.hdr.sgml : 20140508
20140508192006
ACCESSION NUMBER: 0001127602-14-016878
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140506
FILED AS OF DATE: 20140508
DATE AS OF CHANGE: 20140508
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALLERGAN INC
CENTRAL INDEX KEY: 0000850693
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 951622442
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 DUPONT DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 7142464500
MAIL ADDRESS:
STREET 1: P.O. BOX 19534
CITY: IRVINE
STATE: CA
ZIP: 92713-9534
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAY RUSSELL T
CENTRAL INDEX KEY: 0001225960
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10269
FILM NUMBER: 14826629
MAIL ADDRESS:
STREET 1: 2525 DUPONT DR
CITY: IRVINE
STATE: CA
ZIP: 92612
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2014-05-06
0000850693
ALLERGAN INC
AGN
0001225960
RAY RUSSELL T
2525 DUPONT DRIVE
IRVINE
CA
92612
1
Common Stock
2014-05-06
4
A
0
1249
0
A
27167
D
Nonemployee Director Stock Option (Right to Buy)
166.32
2014-05-06
4
A
0
4305
166.32
A
2024-05-06
Common Stock
4305
4305
D
Represents shares of the Issuer's common stock underlying RSUs awarded to the Reporting Person. The RSUs will vest in full upon the earlier to occur of (i) the first anniversary of the grant date, or (ii) the annual meeting during the calendar year following the grant date of the RSUs at which one or more members of the Issuer's board of directors is standing for re-election, provided the Reporting Person remains in the Issuer's service on such date. The RSUs may vest earlier on an accelerated basis in the event of the Reporting Person's termination of service due to death or disability.
The shares of the Issuer's common stock underlying the RSUs will be issued to the Reporting Person no later than ten (10) business days after the RSUs vest.
Includes shares acquired pursuant to dividend equivalent rights attached to RSU previously granted to the Reporting Person.
The per share exercise price is the closing price of Allergan's common stock as of the date of grant.
Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the first stockholder meeting held in 2015 at which one or more members of the board are standing for re-election.
/s/ Matthew J. Maletta, Attorney-in-Fact for Russell T. Ray
2014-05-08